GB774882A - Improvements in or relating to phenthiazine derivatives - Google Patents
Improvements in or relating to phenthiazine derivativesInfo
- Publication number
- GB774882A GB774882A GB18213/54A GB1821354A GB774882A GB 774882 A GB774882 A GB 774882A GB 18213/54 A GB18213/54 A GB 18213/54A GB 1821354 A GB1821354 A GB 1821354A GB 774882 A GB774882 A GB 774882A
- Authority
- GB
- United Kingdom
- Prior art keywords
- phenthiazine
- methyl
- methylphenthiazine
- piperidyl
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A process for the preparation of compounds of the formula: <FORM:0774882/IV(b)/1> and their salts including quaternary ammonium compounds wherein the -CH2- bridge is directly connected to a ring carbon atom of the piperidine nucleus, preferably in the 3- or 4-position, at least one of the benzene rings of the phenthiazine nucleus may contain a halogen, alkyl, alkoxy, phenyl or phenoxy substituent group, preferably in the 3-position and R represents a hydrogen atom or an alkyl group containing not more than 4 carbon atoms or a benzyl group, comprises reducing a phenthiazine compound of the general formula: <FORM:0774882/IV(b)/2> (wherein Hal represents a halogen atom and the phenthiazine nucleus may be substituted as aforesaid) by the application of known methods for the reduction of pyridine derivatives to the corresponding piperidine derivatives. The reduction may be effected catalytically, suitably with an Adams platinum catalyst in absolute ethanol (at ordinary or increased temperature and pressure) or in aqueous alcohol (at increased temperature and pressure). Substituents on the piperidine nitrogen atom may be present in the starting material or be introduced by alkylation processes. In Example (1): 1-methyl-3-(101-phenthiazinylmethyl)-pyridinium iodide is hydrogenated in absolute ethanol in presence of Adams platinum catalyst to give 1-methyl-3-(101-phenthiazinylmethyl)-piperidine hydriodide from which the free base, hydrochloride and picrate are prepared. Similarly obtained are 3-methyl - 10 - (1 - methyl - 3 - piperidyl) - methylphenthiazine; (3) 3 - chloro - 10 - (1 - methyl-3 - piperidyl) methylphenthiazine; (4) 3-methoxy - 10 - (1 - methyl - 3 - piperidyl) methylphenthiazine; (5) 10 - (1 - benzyl - 3 - piperidyl) methylphenthiazine; (6) 3 - chloro-10 - (1 - methyl - 4 - piperidyl) - methylphenthiazine; (7) 10 - (1 - methyl - 4 - piperidyl) methylphenthiazine. In Example (8): 10-(31-pyrdylmethyl)-phenthiazine hydrochloride is hydrogenated in an autoclave at 60-90 kg/cm.2 pressure and 60 DEG C. to give 10-(31-piperidylmethyl)-phenthiazine which is recovered as the methanesulphonate. Starting materials of the second formula above are obtained by the action of a halogenomethylpyridine, preferably in the presence of a condensing agent, on the appropriate phenthiazine and reaction of the product with a compound R Hal. In this manner are prepared 10 - (31 - pyridylmethyl) - phenthiazine and corresponding compounds having 3-methyl, chloro and methoxy substituents, 3-chloro-10-41 - pyridylmethyl) - phenthiazine and 10-(41-pyridylmethyl) - phenthiazine and quaternary compounds of these bases, for use in the above examples. Specification 774,883 is referred to.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB333362X | 1954-06-21 | ||
GB160655X | 1955-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB774882A true GB774882A (en) | 1957-05-15 |
Family
ID=26251762
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB18213/54A Expired GB774882A (en) | 1954-06-21 | 1954-06-21 | Improvements in or relating to phenthiazine derivatives |
GB17971/55A Expired GB774883A (en) | 1954-06-21 | 1954-06-21 | Phenthiazine derivatives |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB17971/55A Expired GB774883A (en) | 1954-06-21 | 1954-06-21 | Phenthiazine derivatives |
Country Status (4)
Country | Link |
---|---|
CH (1) | CH333362A (en) |
DE (1) | DE1052403B (en) |
FR (1) | FR1171946A (en) |
GB (2) | GB774882A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2945855A (en) * | 1958-10-21 | 1960-07-19 | Mead Johnson & Co | 10-(1-substituted-3-pyrrolidylmethyl) phenothiazines |
DE1092476B (en) * | 1958-04-24 | 1960-11-10 | Rhone Poulenc Sa | Process for the preparation of phenthiazine derivatives |
DE1100635B (en) * | 1958-04-22 | 1961-03-02 | Rhone Poulenc Sa | Process for the preparation of phenthiazine derivatives |
EP0404359A1 (en) * | 1989-05-27 | 1990-12-27 | Pfizer Limited | Dibenzothiazepine derivatives useful as antispasmodic agents |
JP2014521678A (en) * | 2011-08-02 | 2014-08-28 | ヘルムホルツ ツェントラム ミュンヘン ドイチェス フォーシュングスツェントラム フュール ゲズントハイト ウント ウンヴェルト ゲーエムベーハー | Selective inhibition of MALT1 protease by phenothiazine derivatives |
WO2022187568A1 (en) * | 2021-03-05 | 2022-09-09 | Monopteros Therapeutics, Inc. | (s)-mepazine salt forms, process of preparing, and formulations thereof |
-
1954
- 1954-06-21 GB GB18213/54A patent/GB774882A/en not_active Expired
- 1954-06-21 GB GB17971/55A patent/GB774883A/en not_active Expired
-
1955
- 1955-06-01 FR FR1171946D patent/FR1171946A/en not_active Expired
- 1955-06-20 DE DES44425A patent/DE1052403B/en active Pending
- 1955-06-20 CH CH333362D patent/CH333362A/en unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1100635B (en) * | 1958-04-22 | 1961-03-02 | Rhone Poulenc Sa | Process for the preparation of phenthiazine derivatives |
DE1092476B (en) * | 1958-04-24 | 1960-11-10 | Rhone Poulenc Sa | Process for the preparation of phenthiazine derivatives |
US2945855A (en) * | 1958-10-21 | 1960-07-19 | Mead Johnson & Co | 10-(1-substituted-3-pyrrolidylmethyl) phenothiazines |
EP0404359A1 (en) * | 1989-05-27 | 1990-12-27 | Pfizer Limited | Dibenzothiazepine derivatives useful as antispasmodic agents |
US5071844A (en) * | 1989-05-27 | 1991-12-10 | Pfizer Inc. | 5,11-dihydrodibenzo[b,e][1,4]-thiazepines useful as gastro intestinal selective calcium antagonists |
JP2014521678A (en) * | 2011-08-02 | 2014-08-28 | ヘルムホルツ ツェントラム ミュンヘン ドイチェス フォーシュングスツェントラム フュール ゲズントハイト ウント ウンヴェルト ゲーエムベーハー | Selective inhibition of MALT1 protease by phenothiazine derivatives |
US9504692B2 (en) | 2011-08-02 | 2016-11-29 | Helmholtz Zentrum Munchen, Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) | Selective inhibition of MALT1 protease by phenothiazine derivatives |
WO2022187568A1 (en) * | 2021-03-05 | 2022-09-09 | Monopteros Therapeutics, Inc. | (s)-mepazine salt forms, process of preparing, and formulations thereof |
Also Published As
Publication number | Publication date |
---|---|
GB774883A (en) | 1957-05-15 |
CH333362A (en) | 1958-10-15 |
DE1052403B (en) | 1959-03-12 |
FR1171946A (en) | 1959-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Turner et al. | Studies on imidazole compounds. I. 4-Methylimidazole and related compounds | |
GB952187A (en) | Thermographic copying materials | |
KR830007644A (en) | Process for preparing carbostyryl compound | |
Adamson et al. | 212. Aminoalkyl tertiary carbinols and derived products. Part III. 3-Tertiary-amino-1-aryl-1-(2-pyridyl)-propan-1-ols and-prop-1-enes | |
GB774882A (en) | Improvements in or relating to phenthiazine derivatives | |
US2695290A (en) | Derivatives of indole and method for the production thereof | |
US3309370A (en) | Bicycloalkyl piperazine derivatives and process | |
Biel | Antihistaminics. I. Some Ethylene Diamines and an Aminoether | |
GB744773A (en) | Indole derivatives | |
US2942003A (en) | Process for preparing naphtho [1, 2-d]-thiazoles | |
GB822592A (en) | Carbazole derivatives and process for the production thereof | |
Kaye | 2-Lepidyl substituted diamines | |
US3105836A (en) | Certain 3-(pyridyl lower alkyl)-2-(tertamino-lower alkyl)-indene quaternary salts | |
Corse et al. | 2-Methoxy-6-chloro-9-(N-substituted-amino)-acridines. II. Compounds Derived from Cyclic Secondary Amines1 | |
GB819886A (en) | New phenthiazine derivatives and processes for their preparation | |
US4590192A (en) | Benzisothiazoles, their pharmaceutical compositions, and method of use | |
KING et al. | Reactions of Pyridine-Type Bases with Iodine and Certain Quinolines or Isoquinolines Containing a Reactive Methyl Group | |
Kostic‐Rajacic et al. | Mixed Dopaminergic/Serotonergic Properties of Several 2‐Substituted 4‐[2‐(5‐Benzimidazole) ethyl]‐1‐arylpiperazines | |
SU414790A3 (en) | METHOD OF OBTAINING 2,3-DIHYDRO-5H-IMIDAZO [2,1-o] IZOINDOL DERIVATIVES12 | |
US3074954A (en) | Heterocyclic compounds | |
GB715236A (en) | Improvements relating to new 1-substituted-4-aminopiperazine derivatives and the preparation thereof | |
GB783627A (en) | Improvements in or relating to methods of preparing chemical compounds containing the pyrrocoline nucleus and new chemical compounds produced thereby | |
Begtrup | 4-(1, 2, 3-triazolio) sulfides, a new mesoionic system | |
Burger et al. | Iodinated Dialkylaminoalkyl Pyridyl Ethers | |
US3880850A (en) | Pyrimido(4,5-d)pyridazine derivatives and process for producing them |